HumulinR (Eli Lilly and Company)


Welcome to the PulseAid listing for the Humulin drug offered from Eli Lilly and Company. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Eli Lilly and Company
NON-PROPRIETARY NAME: Insulin human
SUBSTANCE NAME: INSULIN HUMAN
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: PARENTERAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1983-06-27
END MARKETING DATE: 0000-00-00


Humulin R HUMAN OTC DRUG Details:

Item DescriptionHumulin R from Eli Lilly and Company
LABELER NAME: Eli Lilly and Company
DEA SCHEDULE:
ACTIVE STRENGTH: 100([iU]/mL)
START MARKETING DATE: 1983-06-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0002-8215_08827443-2aa4-4cd9-9657-64a52085fd83
PRODUCT NDC: 0002-8215
APPLICATION NUMBER: NDA018780

Other INSULIN HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
A-S Medication SolutionsHumulin
Eli Lilly and CompanyHumulin
Mannkind CorporationAfrezza
Novo NordiskNovolin
Physicians Total Care, Inc.Humalog 70/30
Sanofi-Aventis U.S. LLCAfrezza
TYA PharmaceuticalsNovolin